(Journal Article): Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.
 
Vijan S, Hofer TP, Hayward RA
 
IN: JAMA 2000; 283(7):889-896
Impact Factor(s) of JAMA: 23.332 (2005), 24.831 (2004), 21.455 (2003), 17.569 (2001)

Fulltext:    HTML 

TYPE OF PUBLICATION: Original article


 
Respond on this Journal Article!
Hint: Your Response should directly apply to Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is Compliance and Adherence.